Latest news
Glucotrack advances LT-100 toward single-injection dosing after FDA Type C meeting and minipig study - TradingViewTradingView · Thu, 30 Jul 2026 21:33:01 GMTGrace Therapeutics Receives Type a Meeting Minutes from FDA and Provides Update on GTx-104 Clinical-Stage Injectable Formulation - marketscreener.commarketscreener.com · Tue, 28 Jul 2026 13:08:20 GMTGrace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 11:15:35 GMTGrace Therapeutics Advances Second U.S. Manufacturing Route for GTx-104 - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT